Total Payments
$62,964
2024 Payments
$15,982
Companies
29
Transactions
340
Medicare Patients
414
Medicare Billing
$77,169
Payment Breakdown by Category
Other$41,800 (66.4%)
Travel$9,435 (15.0%)
Food & Beverage$8,915 (14.2%)
Consulting$2,300 (3.7%)
Education$513.30 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,300 | 23 | 48.1% |
| Honoraria | $11,500 | 8 | 18.3% |
| Travel and Lodging | $9,435 | 36 | 15.0% |
| Food and Beverage | $8,915 | 259 | 14.2% |
| Consulting Fee | $2,300 | 1 | 3.7% |
| Education | $513.30 | 13 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $31,865 | 85 | $0 (2024) |
| Horizon Therapeutics plc | $16,692 | 46 | $0 (2023) |
| Amgen Inc. | $9,054 | 29 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $921.76 | 24 | $0 (2024) |
| Vifor Pharma, Inc. | $879.37 | 21 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $771.51 | 24 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $377.31 | 23 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $300.06 | 12 | $0 (2024) |
| Ardelyx, Inc. | $276.82 | 8 | $0 (2024) |
| Travere Therapeutics, Inc. | $250.98 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,982 | 91 | Amgen Inc. ($8,875) |
| 2023 | $22,968 | 108 | Horizon Therapeutics plc ($16,548) |
| 2022 | $9,012 | 74 | AstraZeneca Pharmaceuticals LP ($7,742) |
| 2021 | $15,002 | 67 | AstraZeneca Pharmaceuticals LP ($13,943) |
All Payment Transactions
340 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $31.35 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/04/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $31.55 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/03/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/18/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: NEPHROLOGY | ||||||
| 11/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/21/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Nephrology | ||||||
| 10/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: DIABETES | ||||||
| 10/10/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: NEPHROLOGY | ||||||
| 10/03/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/03/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Hyperkalemia | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Cardio-renal | ||||||
| 09/25/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $56.02 | General |
| Category: Hyperkalemia | ||||||
| 09/20/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/17/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Nephrology | ||||||
| 09/03/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/27/2024 | Amgen Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| 08/27/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: DIABETES | ||||||
| 08/21/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Hyperkalemia | ||||||
| 08/20/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $18.64 | General |
| 08/13/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $26.13 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 111 | 130 | $72,564 | $17,114 |
| 2022 | 4 | 113 | 148 | $87,839 | $20,412 |
| 2021 | 3 | 99 | 123 | $87,260 | $22,137 |
| 2020 | 3 | 91 | 113 | $83,278 | $17,506 |
Total Patients
414
Total Services
514
Medicare Billing
$77,169
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 42 | 56 | $44,016 | $10,244 | 23.3% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 18 | 22 | $11,198 | $2,834 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 34 | $10,132 | $2,146 | 21.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 18 | $7,218 | $1,890 | 26.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 46 | 69 | $54,234 | $11,718 | 21.6% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 26 | 35 | $17,815 | $4,218 | 23.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 24 | 26 | $10,426 | $3,008 | 28.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 18 | $5,364 | $1,468 | 27.4% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 56 | 76 | $59,736 | $14,831 | 24.8% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 31 | 34 | $17,306 | $4,434 | 25.6% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 12 | 13 | $10,218 | $2,871 | 28.1% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2020 | 54 | 71 | $55,806 | $10,885 | 19.5% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 19 | 22 | $17,292 | $4,170 | 24.1% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2020 | 18 | 20 | $10,180 | $2,451 | 24.1% |
About Luis Polo, NP
Luis Polo, NP is a Nurse Practitioner healthcare provider based in Savannah, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2017. The National Provider Identifier (NPI) number assigned to this provider is 1831624899.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Luis Polo, NP has received a total of $62,964 in payments from pharmaceutical and medical device companies, with $15,982 received in 2024. These payments were reported across 340 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($30,300).
As a Medicare-enrolled provider, Polo has provided services to 414 Medicare beneficiaries, totaling 514 services with total Medicare billing of $77,169. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Registered Nurse
- Location Savannah, GA
- Active Since 04/27/2017
- Last Updated 05/01/2017
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831624899
Products in Payments
- LOKELMA (Drug) $31,468
- KRYSTEXXA (Biological) $23,429
- LUPKYNIS (Drug) $921.76
- ACTHAR (Biological) $752.57
- Veltassa (Drug) $729.91
- Kerendia (Drug) $377.31
- FARXIGA (Drug) $316.69
- JYNARQUE (Drug) $300.06
- RAYALDEE (Drug) $227.58
- IBSRELA (Drug) $176.91
- JARDIANCE (Drug) $156.27
- TARPEYO (Drug) $147.91
- QUTENZA (Drug) $137.13
- Korsuva (Drug) $136.70
- TAVNEOS (Drug) $104.35
- XPHOZAH 30 MG (Drug) $99.91
- MONOFERRIC (Drug) $95.52
- Tavneos (Drug) $75.23
- Auryxia (Drug) $62.17
- Velphoro (Drug) $62.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Savannah
Wallette Widener, Np, NP
Nurse Practitioner — Payments: $17,651
Nurse Practitioner $17,651
Mrs. Angie Moye, Fnp, B.c, FNP, B.C
Nurse Practitioner — Payments: $11,294
Nurse Practitioner $11,294
Amy Carter, Np, NP
Nurse Practitioner — Payments: $8,875
Nurse Practitioner $8,875
Jessica Letcher
Nurse Practitioner — Payments: $8,749
Nurse Practitioner $8,749
Mary Rockwell, Np-C, NP-C
Nurse Practitioner — Payments: $7,754
Nurse Practitioner $7,754
Courtney Morton
Nurse Practitioner — Payments: $6,805
Nurse Practitioner $6,805